BDSX insider transaction filings
BIODESIX INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen BDSX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 15,000 @ $24.47 | EDGAR |
| 2026-08-12 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 13,900 @ $24.25 · Purchase (P): 13,700 @ $24.01 | EDGAR |
| 2026-07-02 | 4 | PATIENCE JOHN — Director | Option exercise (M): 1,361 · Option exercise (M): 1,361 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | PATIENCE JOHN — Director | Option exercise (M): 1,361 · Option exercise (M): 1,361 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Vazquez Chris — Chief Accounting Officer | Option exercise (M): 563 · Sale (S): 211 @ $12.78 · Option exercise (M): 563 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Option exercise (M): 1,469 · Sale (S): 535 @ $12.78 · Option exercise (M): 1,469 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Hutton Scott — President & CEO, Director | Option exercise (M): 4,844 · Sale (S): 1,490 @ $12.78 · Option exercise (M): 4,844 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Pestano Gary Anthony — Chief Development Officer | Option exercise (M): 1,528 · Sale (S): 556 @ $12.78 · Option exercise (M): 1,528 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | O'Kane Kieran — Chief Commercial Officer | Option exercise (M): 1,469 · Sale (S): 535 @ $12.78 · Option exercise (M): 1,469 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Option exercise (M): 2,584 · Sale (S): 941 @ $10.08 · Option exercise (M): 157 (derivative) @ $0 · Option exercise (M): 2,427 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Vazquez Chris — Chief Accounting Officer | Option exercise (M): 263 · Sale (S): 101 @ $10.08 · Option exercise (M): 28 (derivative) @ $0 · Option exercise (M): 235 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | O'Kane Kieran — Chief Commercial Officer | Option exercise (M): 1,600 · Sale (S): 584 @ $10.08 · Option exercise (M): 73 (derivative) @ $0 · Option exercise (M): 1,527 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Pestano Gary Anthony — Chief Development Officer | Option exercise (M): 1,481 · Sale (S): 540 @ $10.08 · Option exercise (M): 68 (derivative) @ $0 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Hutton Scott — President & CEO, Director | Option exercise (M): 9,998 · Sale (S): 3,559 @ $10.08 · Option exercise (M): 610 (derivative) @ $0 · Option exercise (M): 9,388 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 80,000 @ $11.81 · Purchase (P): 20,000 @ $11.80 | EDGAR |
| 2026-01-26 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 82,465 @ $10.96 | EDGAR |
| 2026-01-20 | 4 | Vazquez Chris — Chief Accounting Officer | Option exercise (M): 219 · Sale (S): 83 @ $8.15 · Option exercise (M): 219 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Pestano Gary Anthony — Chief Development Officer | Option exercise (M): 805 · Sale (S): 298 @ $8.15 · Option exercise (M): 805 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | O'Kane Kieran — Chief Commercial Officer | Option exercise (M): 805 · Sale (S): 298 @ $8.15 · Option exercise (M): 805 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Hutton Scott — President & CEO, Director | Option exercise (M): 2,633 · Sale (S): 970 @ $8.15 · Option exercise (M): 2,633 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Option exercise (M): 805 · Sale (S): 298 @ $8.15 · Option exercise (M): 805 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Franchi Jean M. — Director | Grant/award (A): 8,164 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Kennedy Lawrence T. Jr — Director, 10% owner | Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Pestano Gary Anthony — Chief Development Officer | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | O'Kane Kieran — Chief Commercial Officer | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hutton Scott — President & CEO, Director | Grant/award (A): 97,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Grant/award (A): 29,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Vazquez Chris — Chief Accounting Officer | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Strobeck Matthew — Director | Grant/award (A): 6,804 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Kayyem Jon Faiz — Director | Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | MASSARANY HANY — Director | Grant/award (A): 7,484 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PATIENCE JOHN — Director | Option exercise (M): 1,143 · Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 · Option exercise (M): 1,143 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Vazquez Chris — Chief Accounting Officer | Option exercise (M): 31 · Sale (S): 13 @ $7.62 · Option exercise (M): 31 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Pestano Gary Anthony — Chief Development Officer | Option exercise (M): 69 · Sale (S): 23 @ $7.62 · Option exercise (M): 69 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | O'Kane Kieran — Chief Commercial Officer | Option exercise (M): 75 · Sale (S): 25 @ $7.62 · Option exercise (M): 75 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Hutton Scott — President & CEO, Director | Option exercise (M): 611 · Sale (S): 189 @ $7.62 · Option exercise (M): 611 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Option exercise (M): 158 · Sale (S): 50 @ $7.62 · Option exercise (M): 158 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | PATIENCE JOHN — Director | Option exercise (M): 1,144 · Option exercise (M): 1,144 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | SCHULER JACK W — Director, 10% owner | Purchase (P): 142,045 @ $7.04 | EDGAR |
| 2025-09-19 | 4 | SCHULER JACK W — Director, 10% owner | Purchase (P): 15,317 @ $6.04 · Purchase (P): 3,056 @ $6.17 | EDGAR |
| 2025-09-03 | 4 | SCHULER JACK W — Director, 10% owner | Purchase (P): 3,488,372 @ $0.43 | EDGAR |
| 2025-08-14 | 4 | Cowie Robin Harper — CFO, Sec'y & Treasurer | Option exercise (M): 3,157 · Sale (S): 988 @ $0.42 · Option exercise (M): 3,157 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Hutton Scott — President & CEO, Director | Option exercise (M): 12,212 · Sale (S): 3,772 @ $0.42 · Option exercise (M): 12,212 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | O'Kane Kieran — Chief Commercial Officer | Option exercise (M): 1,489 · Sale (S): 476 @ $0.42 · Option exercise (M): 1,489 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Pestano Gary Anthony — Chief Development Officer | Option exercise (M): 1,379 · Sale (S): 442 @ $0.42 · Option exercise (M): 1,379 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Vazquez Chris — Chief Accounting Officer | Option exercise (M): 602 · Sale (S): 228 @ $0.42 · Option exercise (M): 602 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | MASSARANY HANY — Director | Option exercise (M): 26,368 · Option exercise (M): 26,368 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | PATIENCE JOHN — Director | Option exercise (M): 22,874 · Option exercise (M): 22,874 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Kennedy Lawrence T. Jr — Director, 10% owner | Grant/award (A): 68,621 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Franchi Jean M. — Director | Grant/award (A): 92,429 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0 | EDGAR |
Recent 8-K events — BIODESIX INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K/A | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-15 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BDSX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →